2017
DOI: 10.1016/j.micpath.2017.09.041
|View full text |Cite
|
Sign up to set email alerts
|

Gut biofilm forming bacteria in inflammatory bowel disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
32
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(32 citation statements)
references
References 100 publications
0
32
0
Order By: Relevance
“…Techniques including fluorescent in situ hybridization and electron microscopic studies reported the presence of bacterial biofilms in the healthy colon of mice, humans and rats (Palestrant et al, 2004;Swidsinski et al, 2005;Bollinger et al, 2007;Macfarlane et al, 2011;Motta et al, 2015). Altered levels of biofilm associated bacteria such as Bacteroides fragilis, Enterobacteriaceae family were reported in Crohn's disease and inflammatory bowel disease (Masseret et al, 2001;Macfarlane and Dillon, 2007;DuPont and DuPont, 2011;Srivastava et al, 2017). Therefore, the mucus associated bacterial biofilm also could play a role in these disorders.…”
Section: Mucus Interactions With Microbesmentioning
confidence: 99%
“…Techniques including fluorescent in situ hybridization and electron microscopic studies reported the presence of bacterial biofilms in the healthy colon of mice, humans and rats (Palestrant et al, 2004;Swidsinski et al, 2005;Bollinger et al, 2007;Macfarlane et al, 2011;Motta et al, 2015). Altered levels of biofilm associated bacteria such as Bacteroides fragilis, Enterobacteriaceae family were reported in Crohn's disease and inflammatory bowel disease (Masseret et al, 2001;Macfarlane and Dillon, 2007;DuPont and DuPont, 2011;Srivastava et al, 2017). Therefore, the mucus associated bacterial biofilm also could play a role in these disorders.…”
Section: Mucus Interactions With Microbesmentioning
confidence: 99%
“…For example, the induced alteration of the intestinal microbiota after antibiotic use could lead to metabolic disturbances, and therefore increase susceptibility to infections (e.g., fungal and Clostridium difficile infections) 21 . Gut dysbiosis may lead to a number of diseases, including gastrointestinal disorders, obesity, cardiovascular diseases, allergies and central nervous system-related diseases, through a series of alterations 22 - 24 . This alteration involves the disruption of the mucosal barrier, which impairs local immune responses.…”
Section: The Crosstalk Between the Microbiome And Immunitymentioning
confidence: 99%
“…There is no satisfactory and safe treatment option for IBD. Therefore, the current research aims to disrupt biofilms in IBD and concentrates on improving the drug ( Srivastava et al , 2017 ).…”
Section: Gut Floramentioning
confidence: 99%